CD8A and myeloid sarcoma: In the case of MS, molecular mimicry between myelin basic protein (MBP) and EB nuclear antigen 1 (EBNA-1) is well established, and peptides deriving from both MBP and EBNA-1 could activate CD8+ T cells isolated from patients with MS (20).